According to the latest industry analysis, the antibody drug conjugates (ADCs) contract manufacturing market is expected to grow from USD 11.46 Billion in 2025 to USD 25.54 Billion by 2034, registering a CAGR of 9.31% during 2026 to 2034 period. This strong trajectory highlights the growing dependence of pharmaceutical and biotechnology companies on specialized contract manufacturing...